July 23 (Reuters) - Biopharmaceutical firm Telix Pharmaceuticals (TLX) said on Monday it has launched an offering of A$600 million ($397.5 million) of convertible notes due 2029, in a bid to fund key clinical development programs across its theranostics portfolio.
($1 = 1.5094 Australian dollars)
July 23 (Reuters) - Biopharmaceutical firm Telix...
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.31 |
Change
0.680(3.46%) |
Mkt cap ! $6.796B | |||
| Open | High | Low | Value | Volume |
| $20.22 | $20.43 | $19.94 | $39.67M | 1.963M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $20.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.31 | 29999 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |